Frank De Groot
PhD
Senior VP
👥Biography 个人简介
Frank De Groot at Byondis has contributed to the chemistry of antibody-drug conjugates and radioligand therapy, including the development of bifunctional chelators for linking radionuclides (including lutetium-177 and actinium-225) to antibodies for targeted radionuclide therapy. The design and chemistry of radioligand-antibody conjugates is a critical determinant of therapeutic index in radioimmunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Frank De Groot 的研究动态
Follow Frank De Groot's research updates
留下邮箱，当我们发布与 Frank De Groot（Byondis BV）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment